在微质介导的神经炎症中,通过代谢障碍药物缓解CXCL10分泌
Sophia F Oliai1, Daniel C Shippy1, Tyler K Ulland2
1Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, USA.
Journal of neuroimmunology
|May 8, 2024
概括
代谢障碍药物可以通过减少C-X-C动机化学因子连接体10 (CXCL10) 和神经炎症来治疗神经退行性疾病. 在临床前模型中,特雷普罗斯丁尼尔,皮塔瓦斯塔丁和埃普莱伦龙在临床前模型中表现有前途.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢障碍与神经退行性疾病有关.
- 在微质介导的神经炎症中,C-X-C动机化学联体10 (CXCL10) 或干扰素马诱导蛋白10 (IP-10) 是关键.
- 第一种类型的干扰素反应与神经炎症有关.
研究的目的:
- 调查FDA批准的代谢障碍药物是否可以重新用于治疗神经退行性疾病.
- 确定降低CXCL10分泌的药物,这是一个关键的炎症调解剂.
主要方法:
- 在LPS刺激的微质中查代谢障碍药物.
- 进行了剂量反应曲线和细胞毒性测试.
- 评估CXCL10和其他促炎媒介物的减少.
主要成果:
- 特雷普罗斯提尼尔,皮塔瓦斯塔丁和埃普莱伦龙显著降低了CXCL10的分泌.
- 这些药物没有影响微质细胞的活力.
- 其他促炎媒介也被减弱.
结论:
- 针对CXCL10的代谢障碍药物显示出治疗神经退行性疾病的潜力.
- 重用这些药物可能会减轻微质介导的神经炎症.
- prostinil,皮塔瓦斯塔丁和eplerenone是进一步研究的有希望的候选人.
更多相关视频
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
23.7K
09:12Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
15.9K
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
